Investor Relations contacts
Home / Investor Relations / Investor Relations contacts
Contact Investor Relations
Joris Silon
Head of Investor Relations
Christer Gruvris
Executive Director of Investor Relations
BioPharmaceuticals (Cardiovascular, Renal and Metabolism), Finance & Fixed Income
Philip Sparks
Director of Investor Relations
BioPharmaceuticals (Infectious Disease) and Sustainability
Andrew Christmas
Director of Investor Relations
BioPharmaceuticals (Respiratory & Immunology)
Isabel Gibson
Director of Investor Relations
Oncology
Louise Pearson
Director of Investor Relations
Oncology
Lauren Swales
Director of Investor Relations
Rare Disease
Contact us on:
Shareholder Registrar Information
UK Registrar – Computershare Investor Services PLC
+44 (0) 370 707 1682 (International)
US Registrar and Transfer Agent – Computershare Investor Services
+1 (781) 575-2844 (International)
Euroclear Sweden AB - Swedish Central Securities Depository
For holders of shares traded on Stockholm Nasdaq contact Euroclear on:
Individual / Retail shareholders
If you are a retail shareholder and have queries regarding your AstraZeneca shareholding, please contact the applicable registrar in the first instance, using the contact details on this page.
If the applicable registrar is unable to answer your query, please contact:
TR1 notifications
-
Shareholder information
Please find relevant shareholder information and shareholder tools on this page
-
Shareholder FAQs
Answers to frequently asked shareholder questions
-
Governance
We apply the principles of good corporate governance in the UK Corporate Governance Code and related guidance
